News from BAT Research & Development
British American Tobacco’s Award Winning 2015 Science & Technology Report details significant strides in the science of tobacco harm reduction made by BAT’s R&D department over the last year.
BAT has won the award for the ‘Most Impressive Public Service Initiative’ at the Global Tobacco and Nicotine Forum (GTNF) conference in Brussels.
Recent tests conducted by scientists at British American Tobacco (BAT) show that, in stark contrast to cigarette smoke, vapour from the commercially available e-cigarette Vype ePen is less toxic to, and does not cause oxidative stress in, human lung cells.
In the largest study of its kind, scientists from British American Tobacco and Nicoventures have developed a test to examine vaping behaviour, and then applied it to inform their studies on e-cigarettes.
Against a backdrop of a growing number of e-cigarette users globally*, British American Tobacco (BAT) is leading efforts to develop and harmonise standards around vaping products to further reassure consumers of these products potential in reducing the harm from smoking.
New research shows that e-cigarettes are as effective at delivering nicotine as conventional cigarettes, especially when used by experienced vapers.